Addressing how inflammation enhances the efficacy of CFTR modulators might lead to novel therapies exploiting the beneficial effects of inflammation on CFTR rescue, while mitigating its harmful consequences to CF airways. The gene discussed is CFTR; the disease is cystic fibrosis.